By Colin Kellaher Bristol Myers Squibb won a priority review from the Food and Drug Administration for its application seeking expanded approval of its.
By Zaeem Shoaib Shares of Greenwich LifeSciences rose after the company said it is preparing for filing a biologics license application for its experimental.
By Colin Kellaher Candel Therapeutics has won U.S. Food and Drug Administration fast-track designation for its CAN-3110 drug candidate in an aggressive brain.
By Rob Curran Shattuck Labs struck a joint-venture deal with Japanese drugmaker Ono Pharmaceutical to develop treatments for autoimmune and inflammatory.